Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12605396 | Methods of treating mastitis with an orthosomycin antimicrobial compound | 🖼🧊📄§ | 2026-04-21 | 2041-12-23 | 0 | 31 |
| 12605368 | Suppression of neuroinflammation and composition and method therefor | 🖼🧊📄§ | 2026-04-21 | 2041-03-31 | 0 | 31 |
| 12605369 | Amido-substituted heterocyclic compounds and methods of use thereof for the treatment of herpes viruses | 🖼🧊📄§ | 2026-04-21 | 2040-12-16 | 0 | 31 |
| 12605371 | Combination therapy for cancer | 🖼🧊📄§ | 2026-04-21 | 2041-07-26 | 0 | 31 |
| 12605372 | Combination therapy for the treatment of cancer | 🖼🧊📄§ | 2026-04-21 | 2042-11-09 | 0 | 31 |
| 12605382 | Pharmaceutical composition for preventing, alleviating, or treating cancer containing 2,6-dichloro-4-(4-(4-hydroxycyclohexylamino)-7H- pyrrolo[2,3-d]pyrimidin-5-yl)phenol as active ingredient | 🖼🧊📄§ | 2026-04-21 | 2042-05-03 | 0 | 31 |
| 12605387 | Treatment of cancers using PI3 kinase isoform modulators | 🖼🧊📄§ | 2026-04-21 | 2040-07-24 | 0 | 31 |
| 12605434 | Composition for preventing or treating autoimmune diseases | 🖼🧊📄§ | 2026-04-21 | 2042-09-13 | 0 | 31 |
| 12605430 | High-activity blood coagulation factor XI mutant Ala570Thr | 🖼🧊📄§ | 2026-04-21 | 2041-04-13 | 0 | 31 |
| 12605409 | Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders | 🖼🧊📄§ | 2026-04-21 | 2043-04-14 | 0 | 31 |
| 12605359 | Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor and pharmaceutical use therefor | 🖼🧊📄§ | 2026-04-21 | 2041-01-27 | 0 | 31 |
| 12605466 | Enhanced human opsin promoter for rod specific expression | 🖼🧊📄§ | 2026-04-21 | 2040-03-04 | 0 | 31 |
| 12605453 | CP2C-targeting peptide-based anticancer agent | 🖼🧊📄§ | 2026-04-21 | 2040-04-01 | 0 | 31 |
| 12605351 | Method for producing a composition comprising a 3-O-p-coumaroyl ester of tormentic acid from a plant cell culture, applications thereof as antiparasitic agent for the treatment of trypanosomiasis | 🖼🧊📄§ | 2026-04-21 | 2040-02-06 | 0 | 31 |
| 12605440 | Microneedle containing influenza vaccine and influenza vaccine patch containing the same | 🖼🧊📄§ | 2026-04-21 | 2042-12-22 | 0 | 31 |
| 12605342 | Polymer-encapsulated drug particles | 🖼🧊📄§ | 2026-04-21 | 2044-04-10 | 0 | 31 |
| 12605384 | Uses | 🖼🧊📄§ | 2026-04-21 | 2043-06-29 | 0 | 31 |
| 12605397 | Deoxy-cytidine or uridine derivatives for use in cancer therapies | 🖼🧊📄§ | 2026-04-21 | 2044-03-12 | 0 | 31 |
| 12606554 | Compounds and pharmaceutical compositions thereof for the treatment of diseases | 🖼🧊📄§ | 2026-04-21 | 2040-05-25 | 0 | 31 |
| 12606612 | Multivalent DNA antibody constructs and use thereof | 🖼🧊📄§ | 2026-04-21 | 2040-07-31 | 0 | 31 |
| 12606618 | Antagonist anti-NPR1 antibodies and methods of use thereof | 🖼🧊📄§ | 2026-04-21 | 2042-12-06 | 0 | 31 |
| 12605374 | Methods for drug screening and compositions useful for the inhibition of cell proliferation and/or cell survival | 🖼🧊📄§ | 2026-04-21 | 2040-11-30 | 0 | 31 |
| 12606822 | Synthetic modified RNA and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-11-06 | 0 | 31 |
| 12606624 | Antibody that specifically binds to human CTLA4 and medicaments and kits comprising the same | 🖼🧊📄§ | 2026-04-21 | 2043-08-27 | 0 | 31 |
| 12606608 | Modified NK-92 cells, and therapeutic and diagnostic uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-06-09 | 0 | 31 |
| 12606637 | Heparanase-neutralizing A54 monoclonal antibody | 🖼🧊📄§ | 2026-04-21 | 2041-07-06 | 0 | 31 |
| 12605444 | Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same | 🖼🧊📄§ | 2026-04-21 | 2041-01-08 | 0 | 31 |
| 12605438 | SARS-CoV-2 vaccines and antibodies | 🖼🧊📄§ | 2026-04-21 | 2043-03-02 | 0 | 31 |
| 12605389 | PI3K-δ inhibitor for use in treatment regimens | 🖼🧊📄§ | 2026-04-21 | 2042-03-29 | 0 | 31 |
| 12605426 | Pharmaceutical comprising sustained-release microspheres including GLP-1 analogue or pharmaceutically acceptable salt thereof | 🖼🧊📄§ | 2026-04-21 | 2041-02-15 | 0 | 31 |
| 12605373 | Methods and compositions of inhibiting DCN1-UBC12 interaction | 🖼🧊📄§ | 2026-04-21 | 2044-03-05 | 0 | 31 |
| 12605400 | Oligomeric nucleic acid molecule, and application thereof in an acute intermittent porphyria treatment | 🖼🧊📄§ | 2026-04-21 | 2040-04-29 | 0 | 31 |
| 12605418 | Chebulinic acid and its enriched fraction from the fruits of Terminalia chebula for treatment of benign prostatic hyperplasia (BPH) and its preparation thereof | 🖼🧊📄§ | 2026-04-21 | 2041-09-13 | 0 | 31 |
| 12605350 | Composition for preventing, ameliorating, or treating disease caused by nitration of tyrosine in proteins comprising tyrosine as effective component | 🖼🧊📄§ | 2026-04-21 | 2041-06-30 | 0 | 31 |
| 12605358 | Composition for preventing or treating nervous system diseases comprising compound that inhibits mTOR signaling pathway as active ingredient | 🖼🧊📄§ | 2026-04-21 | 2042-02-16 | 0 | 31 |
| 12606834 | Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials | 🖼🧊📄§ | 2026-04-21 | 2041-09-10 | 0 | 31 |
| 12605460 | Stem cell-nano drug delivery system complex, use thereof and method for preparing the same | 🖼🧊📄§ | 2026-04-21 | 2044-06-21 | 0 | 31 |
| 12606604 | Therapeutic compounds and methods | 🖼🧊📄§ | 2026-04-21 | 2041-08-06 | 0 | 31 |
| 12606555 | Chemical compounds | 🖼🧊📄§ | 2026-04-21 | 2042-04-07 | 0 | 31 |
| 12605379 | Methods of improving lung function | 🖼🧊📄§ | 2026-04-21 | 2045-09-12 | 0 | 31 |
| 12606595 | Regentide-041 and composition comprising Regentide-041 for improving skin condition | 🖼🧊📄§ | 2026-04-21 | 2041-06-08 | 0 | 31 |
| 12606635 | Glypican-2-binding moieties, chimeric antigen receptors and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2041-03-12 | 0 | 31 |
| 12606623 | DLL3 targeting chimeric antigen receptors and binding agents | 🖼🧊📄§ | 2026-04-21 | 2043-04-27 | 0 | 31 |
| 12606803 | Methods for growing African swine fever virus in fetal porcine lung alveolar macrophage cells | 🖼🧊📄§ | 2026-04-21 | 2040-07-13 | 0 | 31 |
| 12606869 | Methods for the administration of iloperidone | 🖼🧊📄§ | 2026-04-21 | 2042-04-08 | 0 | 31 |
| 12605443 | SAR-CoV-2 DNA vaccine and method of administering thereof | 🖼🧊📄§ | 2026-04-21 | 2041-10-13 | 0 | 31 |
| 12605395 | Materials and methods for immunosuppressive tumor microenvironment-targeted cancer therapy | 🖼🧊📄§ | 2026-04-21 | 2041-04-01 | 0 | 31 |
| 12605445 | Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer | 🖼🧊📄§ | 2026-04-21 | 2044-01-12 | 0 | 31 |
| 12605399 | Compositions for CFTR MRNA therapy | 🖼🧊📄§ | 2026-04-21 | 2041-05-07 | 0 | 31 |
| 12605452 | Compounds that degrade kinases and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-06-03 | 0 | 31 |